<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">378855999</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180305123335.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161128e20031225xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1515/BC.2003.178</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)gruyter-10.1515/BC.2003.178</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Potent Bivalent Inhibition of Human Tryptase-? by a Synthetic Inhibitor</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[T. Selwood, K.C. Elrod, N. M. Schechter]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Human tryptase-? (HT?) is a unique serine protease exhibiting a frame-like tetramer structure with four active sites directed toward a central pore. Potent inhibition of HT? has been attained using CRA-2059. This compound has two phenylguanidinium head groups connected via a linker capable of spanning between two active sites. The properties of the CRA-2059:HT? interaction were defined in this study. Tightbinding reversible inhibition was observed with an inhibition constant (Ki) of 620 pM, an association rate constant of 7×07 M -1s-1 and a relatively slow dissociation rate constant of 0.04 s-1. Bivalent inhibition was demonstrated by displacement of paminobenzamidine from the primary specificity pocket with a stoichiometry, [CRA-2059]0/[HT?]0, of 0.5. The potency of the bivalent interaction was illustrated by CRA-2059 inhibition of HT?, 24% or 53% inhibited by preincubation with an irreversible inhibitor. Two interactions were observed consistent with mono and bivalent binding; the Ki value for bivalent inhibition was at least 104-fold lower than that for monovalent inhibition. Comparison of the affinities of CRA-2059 and phenylguanidine for HT? finds an approximate doubling of the free energy change upon bivalent binding. This doubling suggests that the linker portion minimally hinders the binding of CRA-2059 to HT?. The potency of CRA-2059 is thus attributable to effective bivalent binding.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Copyright © 2003 by Walter de Gruyter GmbH &amp; Co. KG</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Biochemistry</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Molecular biology</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Cellular biology</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Selwood</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Elrod</subfield>
   <subfield code="D">K.C.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Schechter</subfield>
   <subfield code="D">N. M.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Biological Chemistry</subfield>
   <subfield code="d">Walter de Gruyter</subfield>
   <subfield code="g">384/12(2003-12-25), 1605-1611</subfield>
   <subfield code="x">1431-6730</subfield>
   <subfield code="q">384:12&lt;1605</subfield>
   <subfield code="1">2003</subfield>
   <subfield code="2">384</subfield>
   <subfield code="o">bchm</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1515/BC.2003.178</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1515/BC.2003.178</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Selwood</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Elrod</subfield>
   <subfield code="D">K.C.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Schechter</subfield>
   <subfield code="D">N. M.</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Biological Chemistry</subfield>
   <subfield code="d">Walter de Gruyter</subfield>
   <subfield code="g">384/12(2003-12-25), 1605-1611</subfield>
   <subfield code="x">1431-6730</subfield>
   <subfield code="q">384:12&lt;1605</subfield>
   <subfield code="1">2003</subfield>
   <subfield code="2">384</subfield>
   <subfield code="o">bchm</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="b">CC0</subfield>
   <subfield code="u">http://creativecommons.org/publicdomain/zero/1.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-gruyter</subfield>
  </datafield>
 </record>
</collection>
